跳转至内容
Merck

298263

Sigma-Aldrich

氯化钇 (III)

beads, anhydrous, −10 mesh, 99.9%

别名:

三氯化钇

登录查看公司和协议定价


About This Item

线性分子式:
YCl3
CAS号:
分子量:
195.26
EC號碼:
MDL號碼:
分類程式碼代碼:
12352302

等級

anhydrous

化驗

99.9%

形狀

beads

雜質

<100 ppm

粒徑

−10 mesh

mp

721 °C (lit.)

密度

2.67 g/mL at 25 °C (lit.)

SMILES 字串

Cl[Y](Cl)Cl

InChI

1S/3ClH.Y/h3*1H;/q;;;+3/p-3

InChI 密鑰

PCMOZDDGXKIOLL-UHFFFAOYSA-K

正在寻找类似产品? 访问 产品对比指南

特點和優勢

将与烷氧基钛酸钾反应形成新型含钛陶瓷的前体

包裝

氩气下安瓿瓶包装

訊號詞

Danger

危險聲明

危險分類

Aquatic Acute 1 - Aquatic Chronic 1 - Eye Dam. 1 - Skin Sens. 1B

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Acceleration of the substitution of silanes with Grignard reagents by using either LiCl or YCl3/MeLi.
Naoki Hirone et al.
Angewandte Chemie (International ed. in English), 49(42), 7762-7764 (2010-09-08)
S Hirano et al.
Toxicology and applied pharmacology, 121(2), 224-232 (1993-08-01)
Although radioactive yttrium (Y) has been used for medical treatment, little attention has been directed toward the toxicity of Y. We report time-course and dose-related changes in tissue distribution, subcellular localization, clearance, and acute toxicity of iv-injected yttrium chloride (YCl3)
F Zhang et al.
Physical review letters, 101(14), 148101-148101 (2008-10-15)
Negatively charged globular proteins in solution undergo a condensation upon adding trivalent counterions between two critical concentrations C and C, C <C. This reentrant condensation behavior above C is caused by short-ranged electrostatic interactions between multivalent cations and acidic residues
K Marubashi et al.
Toxicology letters, 99(1), 43-51 (1998-11-04)
We investigated pulmonary clearance of yttrium (Y) and acute lung injury following intratracheal instillation (i.t.) of yttrium chloride (YCl3) in saline- or YCl3-pretreated rats (30 days before the second challenge). About 67% of the initial dose of Y remained in
K Schomäcker et al.
Nuklearmedizin. Nuclear medicine, 36(2), 47-51 (1997-03-01)
Possibilities to exercise an influence on the biodistribution of a tumor-affine 153Sm-preparation, samarium-153-nitrilotriacetate (NTA), were tested. Animals experiments on tumor-bearing mice after additional application of EDTMP (ethylenediamine tetramethylene phosphonate) for the reduction of extratumorale liver-radioactivity and yttrium chloride for the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门